Gossamer Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Our goal is to enhance the lives of peo...
51-200 employees
Gossamer Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Our goal is to enhance the lives of people living with rare diseases.
Frequently Asked Questions
How many employees does Gossamer Bio have?
Gossamer Bio has around 126 employees. As a Biotechnology Research company, they are actively growing their team with 0 open positions.
Why should I join Gossamer Bio?
Gossamer Bio is a leading Biotechnology Research company offering exciting career opportunities. With 0 open positions, now is a great time to join their growing team.
What does Gossamer Bio do?
Gossamer Bio is a Biotechnology Research company. Gossamer Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hype...